237 related articles for article (PubMed ID: 6457531)
1. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Ehrlich CE; Young PC; Cleary RE
Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
[TBL] [Abstract][Full Text] [Related]
2. Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration.
Jänne O; Kauppila A; Kontula K; Syrjälä P; Vihko R
Int J Cancer; 1979 Nov; 24(5):545-54. PubMed ID: 231013
[No Abstract] [Full Text] [Related]
3. [Estrogen and progesterone receptors in endometrial carcinoma during high-dose progestogen (Depo-Provera) therapy].
Thurzó L; Sas M; Falkay G
Orv Hetil; 1986 Oct; 127(43):2613-6. PubMed ID: 2947029
[No Abstract] [Full Text] [Related]
4. Failure of down-regulation of estrogen receptors and progesterone receptors after medroxyprogesterone acetate administration for endometrial hyperplasias.
Masuzawa H; Badokhon NH; Nakayama K; Konishi I; Nikaido T; Fujii S
Cancer; 1994 Oct; 74(8):2321-8. PubMed ID: 7922983
[TBL] [Abstract][Full Text] [Related]
5. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinoma: steroid receptors and response to medroxyprogesterone acetate.
Quinn MA; Cauchi M; Fortune D
Gynecol Oncol; 1985 Jul; 21(3):314-9. PubMed ID: 3159630
[TBL] [Abstract][Full Text] [Related]
7. Hormonal receptors in endometrial neoplasias.
Contreras Ortiz O; Sananes CE
Eur J Gynaecol Oncol; 1988; 9(5):396-8. PubMed ID: 2975993
[TBL] [Abstract][Full Text] [Related]
8. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
[TBL] [Abstract][Full Text] [Related]
9. Cytosol oestradiol and progesterone receptors in endometrial hyperplasia and adenocarcinoma: determination by single saturating dose exchange assays.
Elliott PM; Krozowski Z; Jansen RP
Aust N Z J Obstet Gynaecol; 1980 Nov; 20(4):199-204. PubMed ID: 6940562
[TBL] [Abstract][Full Text] [Related]
10. [Progesterone receptors in endometrial carcinoma and their response to medroxyprogesterone acetate].
Feng YJ; Zhang XY
Zhonghua Fu Chan Ke Za Zhi; 1989 May; 24(3):153-5, 189. PubMed ID: 2530067
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen and endometrial carcinoma: alterations in estrogen and progesterone receptors in untreated patients and combination hormonal therapy in advanced neoplasia.
Carlson JA; Allegra JC; Day TG; Wittliff JL
Am J Obstet Gynecol; 1984 May; 149(2):149-53. PubMed ID: 6232850
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis-related proteins and steroid hormone receptors in normal, hyperplastic, and neoplastic endometrium.
Bozdoğan O; Atasoy P; Erekul S; Bozdoğan N; Bayram M
Int J Gynecol Pathol; 2002 Oct; 21(4):375-82. PubMed ID: 12352186
[TBL] [Abstract][Full Text] [Related]
13. The endometrial adenocarcinoma as a model for hormone-dependency and hormone-responsiveness of gynaecological cancers.
Bonte J
Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):335-41. PubMed ID: 6526120
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and progesterone receptors in endometrial cancer and their prognostic relevance.
Kleine W; Maier T; Geyer H; Pfleiderer A
Gynecol Oncol; 1990 Jul; 38(1):59-65. PubMed ID: 2141316
[TBL] [Abstract][Full Text] [Related]
15. Prediction of clinical outcome with estrogen and progestin receptor concentrations and their relationships to clinical and histopathological variables in endometrial cancer.
Kauppila AJ; Isotalo HE; Kivinen ST; Vihko RK
Cancer Res; 1986 Oct; 46(10):5380-4. PubMed ID: 2944579
[TBL] [Abstract][Full Text] [Related]
16. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
Utaaker E; Iversen OE; Skaarland E
Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
[TBL] [Abstract][Full Text] [Related]
17. Distribution of progesterone receptors between the cytosol and nuclear fraction in normal and neoplastic human endometrium.
Lenasi H; Hudnik-Plevnik T; Rakar S; Rainer S
J Steroid Biochem; 1987 Apr; 26(4):457-62. PubMed ID: 3586661
[TBL] [Abstract][Full Text] [Related]
18. Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma.
Spona J; Ulm R; Bieglmayer C; Husslein P
Gynecol Obstet Invest; 1979; 10(2-3):71-80. PubMed ID: 535775
[TBL] [Abstract][Full Text] [Related]
19. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium.
Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM
Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148
[TBL] [Abstract][Full Text] [Related]
20. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
Geisinger KR; Marshall RB; Kute TE; Homesley HD
Cancer; 1986 Oct; 58(7):1506-17. PubMed ID: 3742469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
